Lung Transplantation for Chronic Graft Versus Host Disease after Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Holm, A. M. [1 ,2 ]
Riise, G. C. [3 ]
Hansson, L. [4 ]
Bjortuft, O. [1 ]
Brinch, L. [5 ]
Simonsen, S. [6 ]
Floisand, Y. [5 ]
机构：
[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Resp Med, N-0027 Oslo, Norway
[2] Univ Oslo, Fac Med, N-0027 Oslo, Norway
[3] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden
[4] Skane Univ Hosp, Dept Resp Med, Lund, Sweden
[5] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Hematol,Dept Med, N-0027 Oslo, Norway
[6] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 04期
关键词：
D O I：
10.1016/j.healun.2012.01.151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页码：S58 / S59
页数：2
相关论文
共 50 条
  • [41] Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation
    Mohty, Mohamad
    LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1696 - 1701
  • [42] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [43] Serum catalase to predict graft-versus-host disease after allogeneic stem cell transplantation
    Kircher, B.
    Schumacher, P.
    Clausen, J.
    Auberger, J.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S118 - S118
  • [44] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [45] Cyclosporine Concentration and Incidence of Acute Graft versus Host Disease after Allogeneic Stem Cell Transplantation
    Josu, B.
    Arrue, L.
    Sainz, A.
    Urreta, I.
    Caminos, N.
    Perez, E.
    Ferreiro, J. J.
    Artola, M.
    Ceberio, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S163 - S164
  • [46] Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation
    Quellmann, Susanne
    Schwarzer, Guido
    Huebel, Kai
    Greb, Alexander
    Engert, Andreas
    Bohlius, Julia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [47] Proteomic patterns and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Chiusolo, P.
    Bellesi, S.
    Fanali, C.
    Giammarco, S.
    Sica, S.
    Inzitari, R.
    Iavarone, F.
    Leone, G.
    Castagnola, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S13 - S13
  • [48] Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    Leithauser, M.
    Kahl, C.
    Aepinus, C.
    Prall, F.
    Maruschke, M.
    Riemer, H.
    Wolff, D.
    Jost, K.
    Hilgendorf, I.
    Freund, M.
    Junghanss, C.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 251 - 257
  • [49] Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation
    Gabelli, Maria
    Marks, David I.
    Sharplin, Kirsty
    Lazareva, Arina
    Mullanfiroze, Khushnuma
    Farish, Susan
    Burridge, Saskia
    Velangi, Mark
    Rampling, Dyanne
    Mozayani, Behrang
    Chiesa, Robert
    Lucchini, Giovanna
    Samarasinghe, Sujith
    Bartram, Jack
    Ghorashian, Sara
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 805 - 811
  • [50] Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
    Lamarthee, Baptiste
    Malard, Florent
    Saas, Philippe
    Mohty, Mohamad
    Gaugler, Beatrice
    FRONTIERS IN IMMUNOLOGY, 2016, 7
12345